Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: Vivos Therapeutics Inc.

MissionIRNewsBreaks – Vivos Therapeutics Inc. Arms Clinicians, Targets Global OSA Market with Alternative Solutions

Vivos Therapeutics, an emerging leader in the treatment of obstructive sleep apnea (“OSA”), is positioned to capitalize on the growing global OSA market, projected to reach $13.24 billion by 2027. The company’s unique approach is to arm clinicians in treating … Continue reading

Posted in Vivos Therapeutics Inc. | Leave a comment

Vivos Therapeutics, Inc. Looking At Significant Forecasted Growth of Sleep Apnea Devices Market

Sleep apnea devices market growth also driven by the current pandemic which has made it exponentially more difficult for patients to seek treatment for their condition Registered with the FDA as a Specification Developer, Vivos develops and markets the first … Continue reading

Posted in MissionIRNewsBreaks, Vivos Therapeutics Inc. | Leave a comment

MissionIRNewsBreaks – Vivos Therapeutics Inc.’s Innovative System Leverages Multidisciplinary Protocol in OSA Treatment

Vivos Therapeutics’ proprietary Vivos System(R) leverages a multidisciplinary treatment protocol comprised of comfortable oral devices and other therapies as needed. Over the course of treatment, typically ranging from 18 to 24 months, most patients experience an increased and enhanced upper … Continue reading

Posted in Vivos Therapeutics Inc. | Leave a comment

Vivos Therapeutics, Inc. Non-Surgical, Non-Invasive, and Cost-Effective Solution, May Help Relieve OSA-Associated Healthcare Costs

Estimates suggest obstructive sleep apnea (“OSA”) costs the US economy $150 billion annually Medicare beneficiaries with obstructive sleep apnea cost taxpayers $19,566 per year Company’s oral appliances have shown to be effective in over 15,000 patients, successfully treated worldwide by … Continue reading

Posted in Vivos Therapeutics Inc. | Leave a comment

MissionIRNewsBreaks – Vivos Therapeutics Inc.’s Novel Vivos System Could Provide Non-Surgical OSA Relief

Vivos Therapeutics, an emerging global leader in the treatment of obstructive sleep apnea (“OSA”), has developed a proprietary system that holds the potential to relieve OSA symptoms in 18-24 months. A recent article further discussing the company reads, “Vivos created … Continue reading

Posted in MissionIRNewsBreaks, Vivos Therapeutics Inc. | Leave a comment

MissionIRNewsBreaks – Vivos Therapeutics Inc. Develops Potential, Nonsurgical Solution for Obstructive Sleep Apnea

Vivos Therapeutics, an emerging global leader in the treatment of obstructive sleep apnea (“OSA”), has developed a groundbreaking remedy that holds the potential to be a possible solution for the life-threatening condition. A recent article further discussing the company reads, … Continue reading

Posted in MissionIRNewsBreaks, Vivos Therapeutics Inc. | Leave a comment

MissionIRNewsBreaks – Why Vivos Therapeutics Inc. Is ‘One to Watch’

Vivos Therapeutics, an emerging global leader in the treatment of obstructive sleep apnea (“OSA”), is on a mission to eliminate OSA using its revolutionary Vivos System(R), a clinical breakthrough in the treatment of sleep apnea caused by craniofacial anatomy development. … Continue reading

Posted in Vivos Therapeutics Inc. | Leave a comment

Vivos Therapeutics Inc. is “One to Watch”

Obstructive sleep apnea affects millions of people of all ages. It is estimated that OSA costs the US economy $165B annually. The Vivos technology represents the first non-surgical, non-invasive and cost-effective solution for the estimated hundreds of millions of people … Continue reading

Posted in Vivos Therapeutics Inc. | Leave a comment